Treatment of idiopathic hemifacial spasm with botulinum toxin
- 29 January 2009
- journal article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 85 (1) , 55-57
- https://doi.org/10.1111/j.1600-0404.1992.tb03995.x
Abstract
Twelve patients with idiopathic hemifacial spasm received treatment with botulinum toxin A over a period of 18 months. Of 76 treatments given, most (94.7%) led to successful relief of eyelid spasms and all treatments were successful for perioral and lower facial muscle spasms. An average dose of 9.3 units of toxin per session was given to produce a mean interval of relief of 10.8 weeks. Blepharoptosis was the only ocular side effect; it was mild, reversible and occurred in 2 patients. However, lower facial palsy was frequent (9 patients); it was mild to moderate in severity but only partially reversible in 8 patients. Dosage for lower facial muscles should therefore be reduced.Keywords
This publication has 15 references indexed in Scilit:
- Assessment [RETIRED]Neurology, 1990
- Botulinum Toxin Injections in the Treatment of Blepharospasm, Hemifacial Spasm, and Eyelid FasciculationsCanadian Journal of Neurological Sciences, 1988
- The Clinical Use of Botulinum ToxinSeminars in Ophthalmology, 1988
- Botulinum A toxin for cranial‐cervical dystoniaNeurology, 1987
- Botulinum Toxin for Benign Essential Blepharospasm, Hemifacial Spasm and Age-Related Lower Eyelid EntropionCanadian Journal of Neurological Sciences, 1987
- Blepharospasm, Meige syndronfie, and hemifacial SpasmNeurology, 1985
- Sequelae of Botulinum Toxin InjectionAmerican Journal of Ophthalmology, 1985
- Carbamazepine for hemi facial spasmNeurology, 1982
- Treatment of hyperkinetic movement disorders with tetrabenazine: A double‐blind crossover studyAnnals of Neurology, 1982
- USE OF CRYSTALLINE TYPE A BOTULINUM TOXIN IN MEDICAL RESEARCHPublished by Elsevier ,1981